Inva Buyout

Inva has activist Alex Denner in control of the board(5/5) and management which has been cut down to 2 people, includes CEO who is also Sarissa Executive. GSK has 30% ownership and probably will be likely buyer, they must have been waiting on Asthma indication approval which came earlier this month.
Beyond Technical AnalysisbuyoutbuyoutsFundamental AnalysisInverse Head and ShouldersTrend Analysis
Leonardi007

Penafian